Amerigen and Ningbo Menovo to Develop Generics for the US

Amerigen, a generic drugmaker with a US/China focus, and China's Ningbo Menovo Pharma will collaborate to develop generic drugs for the US market. Menovo will manufacture the APIs and finished products, while Amerigen will obtain US regulatory approval and commercialize the drugs. In addition, Amerigen will help Menovo gain FDA approval of its finished dose manufacturing facility in Daxie, China. Further details of the collaboration were not disclosed. More details.... Share this with colleagues: // //